Pragmatic Trial Tests AI-Driven Diabetic Retinopathy Screening in Primary Care — Implementation Study Targets 1,700 Patients

References

1. 1.University of Wisconsin, Madison. (2024). Implementing Artificial Intelligence (AI) to Prevent Vision Loss From Diabetes [Clinical trial registration NCT07559292]. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07559292
2. 2.Teo, Z. L., Tham, Y. C., Yu, M., Chee, M. L., Rim, T. H., Cheung, N., Bikbov, M. M., Wang, Y. X., Tang, Y., Lu, Y., Wong, I. Y., Ting, D. S. W., Saw, S. M., Cheng, C. Y., & Wong, T. Y. (2021). Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology, 128(11), 1580-1591. https://doi.org/10.1016/j.ophtha.2021.04.027
3. 3.Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018). Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digital Medicine, 1, 39. https://doi.org/10.1038/s41746-018-0040-6
4. 4.Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., Wykoff, C. C., & Gardner, T. W. (2017). Diabetic retinopathy: A position statement by the American Diabetes Association. Diabetes Care, 40(3), 412-418. https://doi.org/10.2337/dc16-2641
5. 5.Mansberger, S. L., Gleitsmann, K., Gardiner, S., Sheppler, C., Demirel, S., Wooten, K., & Becker, T. M. (2013). Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: A randomized controlled trial. Archives of Ophthalmology, 131(1), 63-69. https://doi.org/10.1001/archophthalmol.2013.4055
6. 6.Ting, D. S. W., Pasquale, L. R., Peng, L., Campbell, J. P., Lee, A. Y., Raman, R., Tan, G. S. W., Schmetterer, L., Keane, P. A., & Wong, T. Y. (2019). Artificial intelligence and deep learning in ophthalmology. British Journal of Ophthalmology, 103(2), 167-175. https://doi.org/10.1136/bjophthalmol-2018-313173